KEYNOTE-799: Phase 2 trial of pembrolizumab plus platinum chemotherapy and radiotherapy for unresectable, locally advanced, stage 3 NSCLC. This is an ASCO Meeting Abstract from the 2021 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results